Literature DB >> 18695749

Mechanisms by which diabetes increases cardiovascular disease.

Christian A Gleissner1, Elena Galkina, Jerry L Nadler, Klaus Ley.   

Abstract

Diabetes mellitus is one of the major risk factors for cardiovascular disease which is the leading cause of death in the U.S. Increasing prevalence of diabetes and diabetic atherosclerosis makes identification of molecular mechanisms by which diabetes promotes atherogenesis an important task. Targeting common pathways may ameliorate both diseases. This review focuses on well known as well as newly discovered mechanisms which may represent promising therapeutic targets.

Entities:  

Year:  2007        PMID: 18695749      PMCID: PMC2504760          DOI: 10.1016/j.ddmec.2007.12.005

Source DB:  PubMed          Journal:  Drug Discov Today Dis Mech        ISSN: 1740-6765


  74 in total

1.  Standards of medical care in diabetes--2007.

Authors: 
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

2.  Hyperglycemia-induced activation of human erythrocyte aldose reductase and alterations in kinetic properties.

Authors:  S K Srivastava; N H Ansari; G A Hair; J Jaspan; M B Rao; B Das
Journal:  Biochim Biophys Acta       Date:  1986-03-28

3.  Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial.

Authors:  Nigishi Hotta; Yasuo Akanuma; Ryuzo Kawamori; Kempei Matsuoka; Yoshitomo Oka; Motoaki Shichiri; Takayoshi Toyota; Mitsuyoshi Nakashima; Isao Yoshimura; Nobuo Sakamoto; Yukio Shigeta
Journal:  Diabetes Care       Date:  2006-07       Impact factor: 19.112

4.  Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells.

Authors:  K Yasunari; M Kohno; H Kano; K Yokokawa; M Minami; J Yoshikawa
Journal:  Circ Res       Date:  1997-12       Impact factor: 17.367

5.  RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

Authors:  Loredana G Bucciarelli; Thoralf Wendt; Wu Qu; Yan Lu; Evanthia Lalla; Ling Ling Rong; Mouza T Goova; Bernhard Moser; Thomas Kislinger; Daniel C Lee; Yogita Kashyap; David M Stern; Ann Marie Schmidt
Journal:  Circulation       Date:  2002-11-26       Impact factor: 29.690

6.  The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus.

Authors:  Adriana Zuccollo; Chaomei Shi; Roberto Mastroianni; Karlene A Maitland-Toolan; Robert M Weisbrod; Mengwei Zang; Shanqin Xu; Bingbing Jiang; Jennifer M Oliver-Krasinski; Antonio J Cayatte; Stefano Corda; Gilbert Lavielle; Tony J Verbeuren; Richard A Cohen
Journal:  Circulation       Date:  2005-10-31       Impact factor: 29.690

Review 7.  The immunogenicity of modified lipoproteins.

Authors:  Maria F Lopes-Virella; Suzanne R Thorpe; M Brooks Derrick; Charlyne Chassereau; Gabriel Virella
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

8.  Insulin resistance and atherosclerosis in diabetes mellitus.

Authors:  Flemming Wollesen; Lars Berglund; Christian Berne
Journal:  Metabolism       Date:  2002-08       Impact factor: 8.694

9.  Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis.

Authors:  Tatsuo Hashimoto; Minoru Kihara; Nozomi Imai; Shin-Ichiro Yoshida; Hiroaki Shimoyamada; Hiroaki Yasuzaki; Junji Ishida; Yoshiyuki Toya; Yoshihiro Kiuchi; Nobuhito Hirawa; Kouichi Tamura; Takuya Yazawa; Hitoshi Kitamura; Akiyoshi Fukamizu; Satoshi Umemura
Journal:  Am J Pathol       Date:  2007-09-20       Impact factor: 4.307

Review 10.  Lipid inflammatory mediators in diabetic vascular disease.

Authors:  Rama Natarajan; Jerry L Nadler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-05-27       Impact factor: 8.311

View more
  22 in total

1.  Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus.

Authors:  Josephin Mosch; Christian A Gleissner; Simon Body; Elena Aikawa
Journal:  Histol Histopathol       Date:  2016-06-29       Impact factor: 2.303

2.  Greater progression of coronary artery calcification is associated with clinically relevant cognitive impairment in type 1 diabetes.

Authors:  Jingchuan Guo; Karen A Nunley; Tina Costacou; Rachel G Miller; Caterina Rosano; Daniel Edmundowicz; Trevor J Orchard
Journal:  Atherosclerosis       Date:  2018-11-08       Impact factor: 5.162

Review 3.  Update on the safety of thiazolidinediones.

Authors:  David C Lieb; Anthony L McCall
Journal:  Curr Diab Rep       Date:  2010-04       Impact factor: 4.810

4.  Effect on oxidative stress, glucose uptake level and lipid droplet content by Apigenin 7, 4'-dimethyl ether isolated from Piper longum L.

Authors:  Mahesh S Krishna; Beena Joy; A Sundaresan
Journal:  J Food Sci Technol       Date:  2014-06-03       Impact factor: 2.701

5.  12(S)-HETE mediates diabetes-induced endothelial dysfunction by activating intracellular endothelial cell TRPV1.

Authors:  Mandy Otto; Clarissa Bucher; Wantao Liu; Melanie Müller; Tobias Schmidt; Marina Kardell; Marvin Noel Driessen; Jan Rossaint; Eric R Gross; Nana-Maria Wagner
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

Review 6.  Lymphocytes in atherosclerosis.

Authors:  Catherine C Hedrick
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02       Impact factor: 8.311

7.  Exercise training during diabetes attenuates cardiac ryanodine receptor dysregulation.

Authors:  Chun-Hong Shao; Xander H T Wehrens; Todd A Wyatt; Sheeva Parbhu; George J Rozanski; Kaushik P Patel; Keshore R Bidasee
Journal:  J Appl Physiol (1985)       Date:  2009-01-08

Review 8.  Searching for novel PET radiotracers: imaging cardiac perfusion, metabolism and inflammation.

Authors:  Caitlund Q Davidson; Christopher P Phenix; T C Tai; Neelam Khaper; Simon J Lees
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-06-05

Review 9.  Immune and inflammatory mechanisms of atherosclerosis (*).

Authors:  Elena Galkina; Klaus Ley
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

10.  Polysaccharide peptide (PsP) Ganoderma lucidum: a potential inducer for vascular repair in type 2 diabetes mellitus model.

Authors:  Teuku Heriansyah; Wiwit Nurwidyaningtyas; Djanggan Sargowo; Cholid Tri Tjahjono; Titin Andri Wihastuti
Journal:  Vasc Health Risk Manag       Date:  2019-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.